1.81k
Citations
22
h-index
28
i10-index
66
Works (all)
1
Aachen papers
Departments & institutes in Aachen
-
Department of Clinical Pharmacy and Toxicology Leiden University Medical Center1 paper · 2025
-
Department of Clinical Pharmacology and Pharmacy Leiden University Medical Center1 paper · 2025
-
Helle-Brit Fiebrich-Westra Leiden University Medical Center1 paper · 2025
-
Isala Oncology Center Leiden University Medical Center1 paper · 2025
-
Department of Clinical Pharmacy Leiden University Medical Center1 paper · 2025
-
Faculty of Pharmaceutical Sciences Leiden University Medical Center1 paper · 2025
-
Department of Epidemiology & Statistics Leiden University Medical Center1 paper · 2025
Affiliations exactly as printed on papers (11)
- 2× Department of Clinical Pharmacy, Isala Hospital, Zwolle, the Netherlands
- 1× Department of Genetic Metabolic Diseases, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands
- 1× Department of Clinical Pharmacy, Isala Hospital Zwolle, Zwolle, The Netherlands
- 1× Clinical Pharmacy, Isala Hospital, Zwolle, Netherlands
- 1× Department of Clinical Pharmacy, Isala, Zwolle, the Netherlands
- 1× Department of Pharmacy Isala Hospital Zwolle The Netherlands
- 1× Isala Diaconessen Hospital Meppel The Netherlands
- 1× Department of Pharmacy, Isala Hospital, Zwolle, The Netherlands
- 1× Isala Diaconessen Hospital, Meppel, The Netherlands
- 1× Helle-Brit Fiebrich-Westra, MD, PhD, Isala Oncology Center, Isala Hospital, Zwolle, NL, Christina Haroun, PharmD, and Remco van der Galiën, PharmD, Department of Clinical Pharmacy, Isala Hospital, Zwolle, NL, and Faculty of Pharmaceutical Sciences, University of Groningen, Groningen, NL, Daphne den Besten-Bertholee, PharmD, Department of Clinical Pharmacy, Isala Hospital, Zwolle, NL, Maarten J. Deenen, PharmD, PhD, Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, NL, Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, NL, Dirk Jan A.R. Moes, PharmD, PhD, Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, NL, Pierre M. Bet, PharmD, PhD, Department of Clinical Pharmacology & Pharmacy, Amsterdam UMC, Amsterdam, NL, Jan Willem B. de Groot, MD, PhD, Isala Oncology Center, Isala Hospital, Zwolle, NL, Richard M. Brohet, PhD, Department of Epidemiology & Statistics, Isala Hospital, Zwolle, NL, A
- 1× Helle-Brit Fiebrich-Westra, MD, PhD, Isala Oncology Center, Isala Hospital, Zwolle, NL, Christina Haroun, PharmD, and Remco van der Galiën, PharmD, Department of Clinical Pharmacy, Isala Hospital, Zwolle, NL, and Faculty of Pharmaceutical Sciences, University of Groningen, Groningen, NL, Daphne den Besten-Bertholee, PharmD, Department of Clinical Pharmacy, Isala Hospital, Zwolle, NL, Maarten J. Deenen, PharmD, PhD, Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, NL, Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, NL, Dirk Jan A.R. Moes, PharmD, PhD, Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, NL, Pierre M. Bet, PharmD, PhD, Department of Clinical Pharmacology & Pharmacy, Amsterdam UMC, Amsterdam, NL, Jan Willem B. de Groot, MD, PhD, Isala Oncology Center, Isala Hospital, Zwolle, NL, Richard M. Brohet, PhD, Department of Epidemiology & Statistics, Isala Hospital, Zwolle, NL, André B.P. van Kuilenb